Authors: ORDING H BRANCADORO V COZZOLINO S ELLIS FR GLAUBER V GONANO EF HALSALL PJ HARTUNG E HEFFRON JJA HEYTENS L KOZAKRIBBENS G KRESS H KRIVOSICHORBER R LEHMANNHORN F MORTIER W NIVOCHE Y RANKLEVTWETMAN E SIGURDSSON S SNOECK M STIEGLITZ P TEGAZZIN V URWYLER A WAPPLER F

Citation: H. Ording et al., IN-VITRO CONTRACTURE TEST FOR DIAGNOSIS OF MALIGNANT HYPERTHERMIA FOLLOWING THE PROTOCOL OF THE EUROPEAN MH GROUP - RESULTS OF TESTING PATIENTS SURVIVING FULMINANT MH AND UNRELATED LOW-RISK SUBJECTS, Acta anaesthesiologica Scandinavica, 41(8), 1997, pp. 955-966

Authors: MORONI I GONANO EF COMI GP TEGAZZIN V PRELLE A BORDONI A BRESOLIN N SCARLATO G

Citation: I. Moroni et al., RYANODINE RECEPTOR GENE POINT MUTATION AND MALIGNANT HYPERTHERMIA SUSCEPTIBILITY, Journal of neurology, 242(3), 1995, pp. 127-133

Authors: BRESOLIN N COMI GP FORTUNATO F MEOLA G GALLANTI A TAJANA A VELICOGNA M GONANO EF NINFALI P PIFFERI S SCARLATO G

Citation: N. Bresolin et al., CLINICAL AND BIOCHEMICAL-EVIDENCE OF SKELETAL-MUSCLE INVOLVEMENT IN GALACTOSE-1-PHOSPHATE URIDYL TRANSFERASE DEFICIENCY, Journal of neurology, 240(5), 1993, pp. 272-277